Skip to main content
Equibles

ROTHSCHILD INVESTMENT LLC

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 85338 CHICAGO, IL
Back to TAK Full portfolio

Position in TAK

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$320,054
+$1,214 QoQ
Shares Held
19,966
+16.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#165
of 378 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in TAK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ROTHSCHILD INVESTMENT LLC holds $2,410,092 across 43 Drug Manufacturers - Specialty & Generic names. TAK ranks #2 (13.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 5,066 $853,823
2 TAK
Takeda Pharmaceutical Co Ltd
This page 		19,966 $320,054
3 VTRS
Viatris Inc
 17,747 $281,822
4 ZTS
Zoetis Inc.
 3,502 $251,653
5 UTHR
UNITED THERAPEUTICS Corp
 350 $189,640
6 PRGO
PERRIGO Co plc
 17,438 $181,180
7 TEVA
Teva Pharmaceutical Industries Ltd
 2,504 $84,835
8 AMRX
Amneal Pharmaceuticals, Inc.
 4,301 $74,450

All Filings in TAK

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $320,054 19,966
2026-03-31 $318,840 17,216
2025-12-31 $256,954 16,482
2025-09-30 $263,110 17,972
2025-06-30 $298,300 19,295
2025-03-31 $288,448 19,398
2024-12-31 $249,176 18,820
2024-09-30 $272,113 19,136
2024-06-30 $318,789 24,636
2024-03-31 $328,873 23,677
2023-12-31 $341,709 23,946